Common Sedative Dexmedetomidine Shows Unexpected Cancer-Fighting Properties
Widely-used anesthetic triggers immune system to attack tumors and enhances checkpoint inhibitor therapy effectiveness.
389 articles in this topic
Widely-used anesthetic triggers immune system to attack tumors and enhances checkpoint inhibitor therapy effectiveness.
Study reveals how common cancer drugs trigger dormant tumor cells to reactivate and spread, offering new prevention strategies.
Major trial finds radiofrequency ablation as effective as surgery for small hepatocellular carcinoma, with fewer complications.
New guidelines address non-financial conflicts that could compromise cancer research integrity and patient outcomes.
New research reveals popular weight-loss medications may reduce cancer risk beyond their metabolic benefits.
Large study reveals immune checkpoint inhibitors cause diabetes in 0.52% of patients, with 90% requiring hospitalization.
New research reveals that pre-treatment fatigue strongly predicts severe adverse effects during cancer therapy.
Patient-facing screening tool integrated with electronic health records significantly improved identification of eligible patients.
Scientists develop brain-penetrating drug that makes glioblastoma cells vulnerable to targeted elimination therapy.
Smaller cancer cells with doubled genomes show enhanced fitness and worse patient outcomes, revealing new prognostic markers.
Lactobacillus johnsonii bacteria enhances immune response and prevents liver cancer recurrence when combined with immunotherapy.
New research reveals how nasopharyngeal cancer cells rewire their metabolism to survive chemotherapy, pointing to potential treatment strategies.